GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
OTP
|
ENSG00000171540.6 | orthopedia homeobox |
PHOX2B
|
ENSG00000109132.5 | paired like homeobox 2B |
LHX1
|
ENSG00000132130.7 | LIM homeobox 1 |
LMX1A
|
ENSG00000162761.10 | LIM homeobox transcription factor 1 alpha |
LHX5
|
ENSG00000089116.3 | LIM homeobox 5 |
HOXC4
|
ENSG00000198353.6 | homeobox C4 |
HOXC4
|
ENSG00000273266.1 | homeobox C4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
LHX5 | hg19_v2_chr12_-_113909877_113909877 | 0.18 | 7.2e-03 | Click! |
PHOX2B | hg19_v2_chr4_-_41750922_41750987 | 0.15 | 2.3e-02 | Click! |
HOXC4 | hg19_v2_chr12_+_54447637_54447661 | -0.04 | 5.9e-01 | Click! |
LHX1 | hg19_v2_chr17_+_35294075_35294102 | -0.03 | 7.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_327537 | 18.14 |
ENST00000602735.1
|
IFITM3
|
interferon induced transmembrane protein 3 |
chr17_+_1674982 | 17.99 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr19_+_50016610 | 17.42 |
ENST00000596975.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr19_+_50016411 | 13.59 |
ENST00000426395.3
ENST00000600273.1 ENST00000599988.1 |
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr4_+_169418195 | 11.94 |
ENST00000261509.6
ENST00000335742.7 |
PALLD
|
palladin, cytoskeletal associated protein |
chr9_+_125132803 | 9.59 |
ENST00000540753.1
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
chr9_+_125133315 | 6.67 |
ENST00000223423.4
ENST00000362012.2 |
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
chr2_-_89327228 | 6.65 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr1_-_92952433 | 6.61 |
ENST00000294702.5
|
GFI1
|
growth factor independent 1 transcription repressor |
chr18_-_47018769 | 6.47 |
ENST00000583637.1
ENST00000578528.1 ENST00000578532.1 ENST00000580387.1 ENST00000579248.1 ENST00000581373.1 |
RPL17
|
ribosomal protein L17 |
chr18_-_47018869 | 6.24 |
ENST00000583036.1
ENST00000580261.1 |
RPL17
|
ribosomal protein L17 |
chr10_+_94451574 | 6.18 |
ENST00000492654.2
|
HHEX
|
hematopoietically expressed homeobox |
chr2_+_90077680 | 6.12 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr11_+_5710919 | 6.10 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr11_+_114168085 | 6.09 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
chrX_+_43515467 | 6.05 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
chr2_+_90273679 | 6.01 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr12_-_10022735 | 5.93 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr18_-_47018897 | 5.59 |
ENST00000418495.1
|
RPL17
|
ribosomal protein L17 |
chr12_+_4385230 | 5.25 |
ENST00000536537.1
|
CCND2
|
cyclin D2 |
chr3_+_157154578 | 5.23 |
ENST00000295927.3
|
PTX3
|
pentraxin 3, long |
chr6_+_26440700 | 5.20 |
ENST00000494393.1
ENST00000482451.1 ENST00000244519.2 ENST00000339789.4 ENST00000471353.1 ENST00000361232.3 ENST00000487627.1 ENST00000496719.1 ENST00000490254.1 ENST00000487272.1 |
BTN3A3
|
butyrophilin, subfamily 3, member A3 |
chr1_-_92371839 | 5.19 |
ENST00000370399.2
|
TGFBR3
|
transforming growth factor, beta receptor III |
chrX_+_1710484 | 5.01 |
ENST00000313871.3
ENST00000381261.3 |
AKAP17A
|
A kinase (PRKA) anchor protein 17A |
chr2_-_89385283 | 4.84 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr9_-_99540328 | 4.79 |
ENST00000223428.4
ENST00000375231.1 ENST00000374641.3 |
ZNF510
|
zinc finger protein 510 |
chr2_+_90211643 | 4.72 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr2_+_103089756 | 4.71 |
ENST00000295269.4
|
SLC9A4
|
solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 |
chr8_-_90769422 | 4.52 |
ENST00000524190.1
ENST00000523859.1 |
RP11-37B2.1
|
RP11-37B2.1 |
chr6_+_26402465 | 4.27 |
ENST00000476549.2
ENST00000289361.6 ENST00000450085.2 ENST00000425234.2 ENST00000427334.1 ENST00000506698.1 |
BTN3A1
|
butyrophilin, subfamily 3, member A1 |
chr7_-_150020578 | 4.12 |
ENST00000478393.1
|
ACTR3C
|
ARP3 actin-related protein 3 homolog C (yeast) |
chr12_-_7655329 | 4.11 |
ENST00000541972.1
|
CD163
|
CD163 molecule |
chr10_-_28571015 | 4.10 |
ENST00000375719.3
ENST00000375732.1 |
MPP7
|
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
chr16_+_28565230 | 3.70 |
ENST00000317058.3
|
CCDC101
|
coiled-coil domain containing 101 |
chr5_+_66300446 | 3.66 |
ENST00000261569.7
|
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr15_-_20193370 | 3.59 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr16_-_28937027 | 3.51 |
ENST00000358201.4
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2 |
chr2_+_68961934 | 3.39 |
ENST00000409202.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr12_-_15114603 | 3.31 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr2_+_68961905 | 3.29 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr7_+_150020363 | 3.15 |
ENST00000359623.4
ENST00000493307.1 |
LRRC61
|
leucine rich repeat containing 61 |
chr7_+_150020329 | 3.13 |
ENST00000323078.7
|
LRRC61
|
leucine rich repeat containing 61 |
chr6_-_32157947 | 3.04 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
chr7_+_134528635 | 3.00 |
ENST00000445569.2
|
CALD1
|
caldesmon 1 |
chr12_-_15114492 | 2.81 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr12_+_26348582 | 2.71 |
ENST00000535504.1
|
SSPN
|
sarcospan |
chr7_+_115862858 | 2.67 |
ENST00000393481.2
|
TES
|
testis derived transcript (3 LIM domains) |
chr2_+_152214098 | 2.64 |
ENST00000243347.3
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6 |
chr6_-_144385698 | 2.59 |
ENST00000444202.1
ENST00000437412.1 |
PLAGL1
|
pleiomorphic adenoma gene-like 1 |
chr4_+_169418255 | 2.50 |
ENST00000505667.1
ENST00000511948.1 |
PALLD
|
palladin, cytoskeletal associated protein |
chr12_-_10282836 | 2.46 |
ENST00000304084.8
ENST00000353231.5 ENST00000525605.1 |
CLEC7A
|
C-type lectin domain family 7, member A |
chr3_-_141747950 | 2.46 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr3_+_45927994 | 2.46 |
ENST00000357632.2
ENST00000395963.2 |
CCR9
|
chemokine (C-C motif) receptor 9 |
chr12_+_75784850 | 2.36 |
ENST00000550916.1
ENST00000435775.1 ENST00000378689.2 ENST00000378692.3 ENST00000320460.4 ENST00000547164.1 |
GLIPR1L2
|
GLI pathogenesis-related 1 like 2 |
chr12_+_104337515 | 2.32 |
ENST00000550595.1
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1 |
chr1_-_153518270 | 2.21 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
chr4_-_185275104 | 2.12 |
ENST00000317596.3
|
RP11-290F5.2
|
RP11-290F5.2 |
chr2_-_241497390 | 2.07 |
ENST00000272972.3
ENST00000401804.1 ENST00000361678.4 ENST00000405523.3 |
ANKMY1
|
ankyrin repeat and MYND domain containing 1 |
chr2_-_241497374 | 2.02 |
ENST00000373318.2
ENST00000406958.1 ENST00000391987.1 ENST00000373320.4 |
ANKMY1
|
ankyrin repeat and MYND domain containing 1 |
chr4_+_155484155 | 1.93 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
chr19_-_14064114 | 1.88 |
ENST00000585607.1
ENST00000538517.2 ENST00000587458.1 ENST00000538371.2 |
PODNL1
|
podocan-like 1 |
chr7_-_144435985 | 1.81 |
ENST00000549981.1
|
TPK1
|
thiamin pyrophosphokinase 1 |
chr19_+_54466179 | 1.79 |
ENST00000270458.2
|
CACNG8
|
calcium channel, voltage-dependent, gamma subunit 8 |
chr6_+_42584847 | 1.77 |
ENST00000372883.3
|
UBR2
|
ubiquitin protein ligase E3 component n-recognin 2 |
chr2_+_68962014 | 1.70 |
ENST00000467265.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr14_-_51027838 | 1.65 |
ENST00000555216.1
|
MAP4K5
|
mitogen-activated protein kinase kinase kinase kinase 5 |
chr2_-_136678123 | 1.63 |
ENST00000422708.1
|
DARS
|
aspartyl-tRNA synthetase |
chr13_-_38172863 | 1.62 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
chr7_-_87342564 | 1.60 |
ENST00000265724.3
ENST00000416177.1 |
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
chr12_+_59989918 | 1.57 |
ENST00000547379.1
ENST00000549465.1 |
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr4_+_155484103 | 1.57 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr12_+_26348246 | 1.57 |
ENST00000422622.2
|
SSPN
|
sarcospan |
chr2_-_25391507 | 1.54 |
ENST00000380794.1
|
POMC
|
proopiomelanocortin |
chr7_-_38305279 | 1.53 |
ENST00000443402.2
|
TRGC1
|
T cell receptor gamma constant 1 |
chr16_-_28634874 | 1.52 |
ENST00000395609.1
ENST00000350842.4 |
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
chr7_+_102553430 | 1.49 |
ENST00000339431.4
ENST00000249377.4 |
LRRC17
|
leucine rich repeat containing 17 |
chr12_+_25205666 | 1.45 |
ENST00000547044.1
|
LRMP
|
lymphoid-restricted membrane protein |
chr2_-_25391772 | 1.39 |
ENST00000405623.1
|
POMC
|
proopiomelanocortin |
chr12_-_9913489 | 1.35 |
ENST00000228434.3
ENST00000536709.1 |
CD69
|
CD69 molecule |
chr13_-_99910673 | 1.32 |
ENST00000397473.2
ENST00000397470.2 |
GPR18
|
G protein-coupled receptor 18 |
chr3_-_114477787 | 1.31 |
ENST00000464560.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr17_-_53800217 | 1.27 |
ENST00000424486.2
|
TMEM100
|
transmembrane protein 100 |
chr2_-_25391468 | 1.27 |
ENST00000395826.2
|
POMC
|
proopiomelanocortin |
chr15_+_75970672 | 1.26 |
ENST00000435356.1
|
AC105020.1
|
Uncharacterized protein; cDNA FLJ12988 fis, clone NT2RP3000080 |
chrX_-_100872911 | 1.26 |
ENST00000361910.4
ENST00000539247.1 ENST00000538627.1 |
ARMCX6
|
armadillo repeat containing, X-linked 6 |
chr3_-_114477962 | 1.24 |
ENST00000471418.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr20_-_18477862 | 1.22 |
ENST00000337227.4
|
RBBP9
|
retinoblastoma binding protein 9 |
chr15_+_64680003 | 1.22 |
ENST00000261884.3
|
TRIP4
|
thyroid hormone receptor interactor 4 |
chr12_-_112123524 | 1.21 |
ENST00000327551.6
|
BRAP
|
BRCA1 associated protein |
chr6_+_114178512 | 1.18 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chr2_-_25391425 | 1.14 |
ENST00000264708.3
ENST00000449220.1 |
POMC
|
proopiomelanocortin |
chr12_-_22063787 | 1.14 |
ENST00000544039.1
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
chr2_-_163008903 | 1.10 |
ENST00000418842.2
ENST00000375497.3 |
GCG
|
glucagon |
chr16_+_31271274 | 1.09 |
ENST00000287497.8
ENST00000544665.3 |
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit) |
chr10_-_75415825 | 1.04 |
ENST00000394810.2
|
SYNPO2L
|
synaptopodin 2-like |
chr7_-_107642348 | 1.03 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
chr6_+_26365443 | 1.00 |
ENST00000527422.1
ENST00000356386.2 ENST00000396934.3 ENST00000377708.2 ENST00000396948.1 ENST00000508906.2 |
BTN3A2
|
butyrophilin, subfamily 3, member A2 |
chr5_+_81575281 | 0.99 |
ENST00000380167.4
|
ATP6AP1L
|
ATPase, H+ transporting, lysosomal accessory protein 1-like |
chr6_+_26402517 | 0.97 |
ENST00000414912.2
|
BTN3A1
|
butyrophilin, subfamily 3, member A1 |
chrX_+_107288239 | 0.95 |
ENST00000217957.5
|
VSIG1
|
V-set and immunoglobulin domain containing 1 |
chr14_+_55595762 | 0.95 |
ENST00000254301.9
|
LGALS3
|
lectin, galactoside-binding, soluble, 3 |
chr4_-_120243545 | 0.94 |
ENST00000274024.3
|
FABP2
|
fatty acid binding protein 2, intestinal |
chr19_-_58326267 | 0.93 |
ENST00000391701.1
|
ZNF552
|
zinc finger protein 552 |
chr7_-_140482926 | 0.91 |
ENST00000496384.2
|
BRAF
|
v-raf murine sarcoma viral oncogene homolog B |
chr1_-_211307404 | 0.87 |
ENST00000367007.4
|
KCNH1
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
chr13_+_53602894 | 0.86 |
ENST00000219022.2
|
OLFM4
|
olfactomedin 4 |
chrX_-_18690210 | 0.85 |
ENST00000379984.3
|
RS1
|
retinoschisin 1 |
chr12_+_26348429 | 0.85 |
ENST00000242729.2
|
SSPN
|
sarcospan |
chr17_+_74463650 | 0.84 |
ENST00000392492.3
|
AANAT
|
aralkylamine N-acetyltransferase |
chr15_+_93443419 | 0.81 |
ENST00000557381.1
ENST00000420239.2 |
CHD2
|
chromodomain helicase DNA binding protein 2 |
chr2_-_79386786 | 0.80 |
ENST00000393878.1
ENST00000305165.2 ENST00000409839.3 |
REG3A
|
regenerating islet-derived 3 alpha |
chr4_+_80584903 | 0.75 |
ENST00000506460.1
|
RP11-452C8.1
|
RP11-452C8.1 |
chr2_+_234826016 | 0.75 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
chr8_-_86253888 | 0.74 |
ENST00000522389.1
ENST00000432364.2 ENST00000517618.1 |
CA1
|
carbonic anhydrase I |
chr1_+_157963063 | 0.73 |
ENST00000360089.4
ENST00000368173.3 ENST00000392272.2 |
KIRREL
|
kin of IRRE like (Drosophila) |
chr20_+_55904815 | 0.72 |
ENST00000371263.3
ENST00000345868.4 ENST00000371260.4 ENST00000418127.1 |
SPO11
|
SPO11 meiotic protein covalently bound to DSB |
chr14_+_103851712 | 0.72 |
ENST00000440884.3
ENST00000416682.2 ENST00000429436.2 ENST00000303622.9 |
MARK3
|
MAP/microtubule affinity-regulating kinase 3 |
chr19_+_48949030 | 0.72 |
ENST00000253237.5
|
GRWD1
|
glutamate-rich WD repeat containing 1 |
chr6_-_29527702 | 0.71 |
ENST00000377050.4
|
UBD
|
ubiquitin D |
chr19_+_21264980 | 0.71 |
ENST00000596053.1
ENST00000597086.1 ENST00000596143.1 ENST00000596367.1 ENST00000601416.1 |
ZNF714
|
zinc finger protein 714 |
chr9_+_34652164 | 0.68 |
ENST00000441545.2
ENST00000553620.1 |
IL11RA
|
interleukin 11 receptor, alpha |
chr18_-_53177984 | 0.67 |
ENST00000543082.1
|
TCF4
|
transcription factor 4 |
chr19_+_21324827 | 0.66 |
ENST00000600692.1
ENST00000599296.1 ENST00000594425.1 ENST00000311048.7 |
ZNF431
|
zinc finger protein 431 |
chr17_-_64225508 | 0.64 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr17_-_39093672 | 0.64 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
chr9_-_77567743 | 0.63 |
ENST00000376854.5
|
C9orf40
|
chromosome 9 open reading frame 40 |
chr18_-_52989217 | 0.63 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chr14_-_106552755 | 0.63 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
chr18_-_51750948 | 0.62 |
ENST00000583046.1
ENST00000398398.2 |
MBD2
|
methyl-CpG binding domain protein 2 |
chr20_-_33735070 | 0.57 |
ENST00000374491.3
ENST00000542871.1 ENST00000374492.3 |
EDEM2
|
ER degradation enhancer, mannosidase alpha-like 2 |
chr16_-_66583701 | 0.55 |
ENST00000527800.1
ENST00000525974.1 ENST00000563369.2 |
TK2
|
thymidine kinase 2, mitochondrial |
chr6_-_10838736 | 0.54 |
ENST00000536370.1
ENST00000474039.1 |
MAK
|
male germ cell-associated kinase |
chr22_+_40297079 | 0.53 |
ENST00000344138.4
ENST00000543252.1 |
GRAP2
|
GRB2-related adaptor protein 2 |
chr5_-_70316737 | 0.53 |
ENST00000194097.4
|
NAIP
|
NLR family, apoptosis inhibitory protein |
chr4_-_170948361 | 0.52 |
ENST00000393702.3
|
MFAP3L
|
microfibrillar-associated protein 3-like |
chr6_-_10838710 | 0.52 |
ENST00000313243.2
|
MAK
|
male germ cell-associated kinase |
chr1_+_180601139 | 0.52 |
ENST00000367590.4
ENST00000367589.3 |
XPR1
|
xenotropic and polytropic retrovirus receptor 1 |
chr22_+_40297105 | 0.51 |
ENST00000540310.1
|
GRAP2
|
GRB2-related adaptor protein 2 |
chr10_-_102989551 | 0.51 |
ENST00000370193.2
|
LBX1
|
ladybird homeobox 1 |
chr16_-_66584059 | 0.50 |
ENST00000417693.3
ENST00000544898.1 ENST00000569718.1 ENST00000527284.1 ENST00000299697.7 ENST00000451102.2 |
TK2
|
thymidine kinase 2, mitochondrial |
chrX_+_77166172 | 0.50 |
ENST00000343533.5
ENST00000350425.4 ENST00000341514.6 |
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide |
chr14_-_106668095 | 0.49 |
ENST00000390606.2
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
chrX_+_47696275 | 0.49 |
ENST00000376954.1
ENST00000338637.7 |
ZNF81
|
zinc finger protein 81 |
chr16_+_12059091 | 0.47 |
ENST00000562385.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr1_-_57045228 | 0.45 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr18_-_51751132 | 0.45 |
ENST00000256429.3
|
MBD2
|
methyl-CpG binding domain protein 2 |
chr5_-_149829244 | 0.45 |
ENST00000312037.5
|
RPS14
|
ribosomal protein S14 |
chr7_-_102283238 | 0.44 |
ENST00000340457.8
|
UPK3BL
|
uroplakin 3B-like |
chr4_-_39979576 | 0.43 |
ENST00000303538.8
ENST00000503396.1 |
PDS5A
|
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) |
chr10_-_115904361 | 0.43 |
ENST00000428953.1
ENST00000543782.1 |
C10orf118
|
chromosome 10 open reading frame 118 |
chr3_+_12329397 | 0.43 |
ENST00000397015.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
chr8_-_57123815 | 0.43 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
chr1_+_168250194 | 0.43 |
ENST00000367821.3
|
TBX19
|
T-box 19 |
chr6_-_7313381 | 0.42 |
ENST00000489567.1
ENST00000479365.1 ENST00000462112.1 ENST00000397511.2 ENST00000534851.1 ENST00000474597.1 ENST00000244763.4 |
SSR1
|
signal sequence receptor, alpha |
chr18_-_52989525 | 0.39 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr17_-_72772462 | 0.39 |
ENST00000582870.1
ENST00000581136.1 ENST00000357814.3 ENST00000579218.1 ENST00000583476.1 ENST00000580301.1 ENST00000583757.1 ENST00000582524.1 |
NAT9
|
N-acetyltransferase 9 (GCN5-related, putative) |
chr19_+_23945768 | 0.38 |
ENST00000486528.1
ENST00000496398.1 |
RPSAP58
|
ribosomal protein SA pseudogene 58 |
chrX_+_55744228 | 0.37 |
ENST00000262850.7
|
RRAGB
|
Ras-related GTP binding B |
chr13_-_36050819 | 0.36 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
chr9_+_90112590 | 0.36 |
ENST00000472284.1
|
DAPK1
|
death-associated protein kinase 1 |
chr20_-_56265680 | 0.35 |
ENST00000414037.1
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr2_+_109237717 | 0.34 |
ENST00000409441.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr8_+_121137333 | 0.33 |
ENST00000309791.4
ENST00000297848.3 ENST00000247781.3 |
COL14A1
|
collagen, type XIV, alpha 1 |
chrX_+_107288197 | 0.33 |
ENST00000415430.3
|
VSIG1
|
V-set and immunoglobulin domain containing 1 |
chr10_-_105845674 | 0.33 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
chr3_+_149191723 | 0.33 |
ENST00000305354.4
|
TM4SF4
|
transmembrane 4 L six family member 4 |
chr6_-_112115074 | 0.32 |
ENST00000368667.2
|
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr5_+_95066823 | 0.32 |
ENST00000506817.1
ENST00000379982.3 |
RHOBTB3
|
Rho-related BTB domain containing 3 |
chr4_-_119759795 | 0.32 |
ENST00000419654.2
|
SEC24D
|
SEC24 family member D |
chr2_+_102953608 | 0.30 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
chr3_+_39424828 | 0.30 |
ENST00000273158.4
ENST00000431510.1 |
SLC25A38
|
solute carrier family 25, member 38 |
chr4_-_122854612 | 0.30 |
ENST00000264811.5
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3 |
chr8_-_49833978 | 0.30 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
chr12_+_122688090 | 0.29 |
ENST00000324189.4
ENST00000546192.1 |
B3GNT4
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 |
chr3_-_141719195 | 0.29 |
ENST00000397991.4
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr3_+_12329358 | 0.29 |
ENST00000309576.6
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
chr21_-_31538971 | 0.29 |
ENST00000286808.3
|
CLDN17
|
claudin 17 |
chr14_+_102276192 | 0.28 |
ENST00000557714.1
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma |
chr6_-_109702885 | 0.28 |
ENST00000504373.1
|
CD164
|
CD164 molecule, sialomucin |
chr4_-_76944621 | 0.26 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
chr3_+_141106643 | 0.26 |
ENST00000514251.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
chr16_-_30122717 | 0.26 |
ENST00000566613.1
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chr12_-_117319236 | 0.26 |
ENST00000257572.5
|
HRK
|
harakiri, BCL2 interacting protein (contains only BH3 domain) |
chr12_-_117318788 | 0.25 |
ENST00000550505.1
|
HRK
|
harakiri, BCL2 interacting protein (contains only BH3 domain) |
chr7_-_22862448 | 0.25 |
ENST00000358435.4
|
TOMM7
|
translocase of outer mitochondrial membrane 7 homolog (yeast) |
chr3_-_99569821 | 0.21 |
ENST00000487087.1
|
FILIP1L
|
filamin A interacting protein 1-like |
chr1_+_81771806 | 0.20 |
ENST00000370721.1
ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2
|
latrophilin 2 |
chr19_-_19887185 | 0.20 |
ENST00000590092.1
ENST00000589910.1 ENST00000589508.1 ENST00000586645.1 ENST00000586816.1 ENST00000588223.1 ENST00000586885.1 |
LINC00663
|
long intergenic non-protein coding RNA 663 |
chr9_+_90112767 | 0.20 |
ENST00000408954.3
|
DAPK1
|
death-associated protein kinase 1 |
chr6_+_25754927 | 0.20 |
ENST00000377905.4
ENST00000439485.2 |
SLC17A4
|
solute carrier family 17, member 4 |
chr5_-_88119580 | 0.19 |
ENST00000539796.1
|
MEF2C
|
myocyte enhancer factor 2C |
chr4_+_5527117 | 0.19 |
ENST00000505296.1
|
C4orf6
|
chromosome 4 open reading frame 6 |
chr12_-_25348007 | 0.17 |
ENST00000354189.5
ENST00000545133.1 ENST00000554347.1 ENST00000395987.3 ENST00000320267.9 ENST00000395990.2 ENST00000537577.1 |
CASC1
|
cancer susceptibility candidate 1 |
chr9_-_26947453 | 0.17 |
ENST00000397292.3
|
PLAA
|
phospholipase A2-activating protein |
chr7_+_138145076 | 0.16 |
ENST00000343526.4
|
TRIM24
|
tripartite motif containing 24 |
chr6_-_133035185 | 0.16 |
ENST00000367928.4
|
VNN1
|
vanin 1 |
chr8_-_49834299 | 0.16 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
chr2_+_102615416 | 0.15 |
ENST00000393414.2
|
IL1R2
|
interleukin 1 receptor, type II |
chr4_-_39033963 | 0.15 |
ENST00000381938.3
|
TMEM156
|
transmembrane protein 156 |
chr1_-_114414316 | 0.14 |
ENST00000528414.1
ENST00000538253.1 ENST00000460620.1 ENST00000420377.2 ENST00000525799.1 ENST00000359785.5 |
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 31.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
3.7 | 18.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
2.2 | 6.6 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.1 | 6.2 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
1.7 | 5.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.5 | 6.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.0 | 5.2 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.9 | 16.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 18.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 5.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.6 | 14.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.6 | 6.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.6 | 4.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.5 | 1.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.5 | 1.6 | GO:1990523 | bone regeneration(GO:1990523) |
0.5 | 1.8 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.4 | 6.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 3.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 3.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 0.9 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
0.3 | 1.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 1.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.3 | 4.7 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 0.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.3 | 0.8 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.3 | 5.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 1.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 1.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.3 | 6.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 1.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 1.6 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.6 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 0.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.7 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.2 | 2.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 0.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.2 | 1.1 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.2 | 0.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.1 | 0.7 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 22.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 2.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.9 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 18.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 6.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 3.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 2.6 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 2.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 4.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 1.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.5 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 1.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.9 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.7 | GO:0045141 | meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 2.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 9.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 1.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 4.9 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.1 | 1.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 0.3 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.0 | 3.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 2.5 | GO:0032760 | positive regulation of interleukin-6 production(GO:0032755) positive regulation of tumor necrosis factor production(GO:0032760) |
0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 1.2 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.0 | 0.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 2.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.0 | 0.2 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 1.9 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 5.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 1.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.0 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 1.2 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 1.2 | GO:0042127 | regulation of cell proliferation(GO:0042127) |
0.0 | 1.4 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 1.8 | GO:0031295 | T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.3 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.0 | 0.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 1.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 18.0 | GO:0043203 | axon hillock(GO:0043203) |
1.3 | 5.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 5.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.4 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.0 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.3 | 4.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 3.0 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 3.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 14.4 | GO:0002102 | podosome(GO:0002102) |
0.2 | 4.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.1 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.2 | 17.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 5.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 16.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 18.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 2.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 8.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 5.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 4.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 11.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.9 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 7.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 5.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 5.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 3.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 3.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 3.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 27.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.0 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 3.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 31.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
4.1 | 16.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
1.5 | 6.1 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
1.3 | 5.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 6.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.7 | 7.5 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 14.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 6.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 5.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 4.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 6.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.4 | 1.8 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.3 | 1.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.3 | 1.6 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 0.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.5 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) steroid sulfotransferase activity(GO:0050294) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 16.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 31.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.9 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 2.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 3.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 2.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 4.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 2.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.9 | GO:0070492 | phosphatidylinositol-5-phosphate binding(GO:0010314) oligosaccharide binding(GO:0070492) |
0.1 | 1.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 3.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 13.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.6 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 8.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.0 | 0.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 4.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 1.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 3.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 1.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.1 | GO:0046978 | peptide antigen-transporting ATPase activity(GO:0015433) TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 1.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 4.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 5.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 3.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 8.7 | GO:0019901 | protein kinase binding(GO:0019901) |
0.0 | 0.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 5.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 1.5 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 5.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 5.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 6.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 15.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 10.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 6.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 4.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 3.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 5.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 6.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 3.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 15.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 16.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 2.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 18.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 14.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 4.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 7.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 3.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 4.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 1.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 3.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |